Image for illustrative purposes only. Not a real photo.

Amplia Therapeutics partners with Eli Lilly on 2026 trial

Written by Liezl GambePublished Aug 4, 2026, 6:17 AM

Amplia Therapeutics (ASX:ATX) partnered with Eli Lilly & Company (NYSE:LLY) for a Phase 1b/2b trial starting in late 2026.

More ways to discover